Brandywine Managers’s Eli Lilly LLY Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q2
$428K Sell
357
-340
-49% -$347K 0.21% 39
2026
Q1
$641K Hold
697
0.38% 23
2025
Q4
$749K Hold
697
0.37% 22
2025
Q3
$532K Hold
697
0.51% 25
2025
Q2
$543K Hold
697
0.54% 22
2025
Q1
$576K Hold
697
0.69% 22
2024
Q4
$538K Hold
697
0.57% 23
2024
Q3
$618K Buy
697
+109
+19% +$98K 0.66% 22
2024
Q2
$532K Buy
+588
New +$470K 0.56% 24

Other funds holding LLY

Brandywine Managers's LLY Position: Q2 2026 in Review

Brandywine Managers reduced its Eli Lilly (LLY) stake by 49% in Q2 2026, selling an estimated $347K and leaving 357 shares worth $428K. The position accounts for 0.21% of the portfolio, ranked #39.

Brandywine Managers first reported a position in LLY in Q2 2024 and has held it in 9 quarters since. The position peaked at $749K in Q4 2025. 4,624 funds tracked by Wall St. Rank hold LLY as of Q2 2026.

  • Brandywine Managers held 357 shares of Eli Lilly worth $428K as of Q2 2026.
  • Brandywine Managers sold 340 Eli Lilly shares in Q2 2026, an estimated $347K.
  • Eli Lilly made up 0.21% of Brandywine Managers's portfolio in Q2 2026, its #39 holding.
  • Brandywine Managers first reported a position in Eli Lilly in Q2 2024 and has held it in 9 quarters since.
  • Brandywine Managers's Eli Lilly position peaked at $749K in Q4 2025.
  • 4,624 funds tracked by Wall St. Rank held Eli Lilly as of Q2 2026.

Based on Brandywine Managers's 13F filing for Q2 2026, filed 14 Aug 2026.